1st Quarter - Report
ALPINE GROUP PARTNERS, LLC. for EMERGENT BIOSOLUTIONS
Client
Income
$50,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines State opioid response (SOR) Grant funding Substance Abuse and Mental Health Block Grant (SABG) funding
| Lobbyist | Covered position, as disclosed |
|---|---|
| KEENAN AUSTIN REED | Chief of Staff, Rep. Donald McEachin; Deputy Chief of Staff, Rep. Frederica S. Wilson |
| COURTNEY JOHNSON | — |
| NEAL PATEL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.